Literature DB >> 23459830

Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Julieta M Ceruti1, María F Ogara, Camino Menéndez, Ignacio Palmero, Eduardo T Cánepa.   

Abstract

ING proteins are tumor suppressors involved in the regulation of gene transcription, cell cycle arrest, apoptosis, and senescence. Here, we show that ING1b expression is upregulated by several DNA-damaging agents, in a p53-independent manner. ING1b stimulates DNA repair of a variety of DNA lesions requiring activation of multiple DNA repair pathways. Moreover, Ing1(-/-) cells showed impaired genomic DNA repair after H2O2 and neocarzinostatin treatment and this defect was reverted by overexpression of ING1b. Two tumor-derived ING1 mutants failed to promote DNA repair highlighting the physiological importance of the integrity of the PHD domain for ING1b DNA repair activity and suggesting a role in the prevention of tumor progression. Ing(-/-) cells showed higher basal levels of γ-H2AX and, upon DNA damage, γ-H2AX increase was greater and with faster kinetics compared to wild-type cells. Chromatin relaxation by Trichostatin A led to an exacerbated damage signal in both types of cells, but this effect was dependent on Ing1 status, and more pronounced in wild-type cells. Our results suggest that ING1 acts at early stages of the DNA damage response activating a variety of repair mechanisms and that this function of ING1 is targeted in tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459830     DOI: 10.1007/s11010-013-1601-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  55 in total

1.  Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  P Saugier-Veber; N Drouot; L M Wolf; J M Kuhn; T Frébourg; H Lefebvre
Journal:  Eur J Endocrinol       Date:  2001-04       Impact factor: 6.664

Review 2.  Oxidative DNA damage repair in mammalian cells: a new perspective.

Authors:  Tapas K Hazra; Aditi Das; Soumita Das; Sujata Choudhury; Yoke W Kow; Rabindra Roy
Journal:  DNA Repair (Amst)       Date:  2006-11-20

3.  A PHD finger motif in the C terminus of RAG2 modulates recombination activity.

Authors:  Sheryl K Elkin; Dmitri Ivanov; Mark Ewalt; Colin G Ferguson; Sven G Hyberts; Zhen-Yu J Sun; Glenn D Prestwich; Junying Yuan; Gerhard Wagner; Marjorie A Oettinger; Or P Gozani
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

4.  Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).

Authors:  A Kuzmichev; Y Zhang; H Erdjument-Bromage; P Tempst; D Reinberg
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Authors:  I Garkavtsev; I A Grigorian; V S Ossovskaya; M V Chernov; P M Chumakov; A V Gudkov
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

Review 6.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

7.  ING1b decreases cell proliferation through p53-dependent and -independent mechanisms.

Authors:  Fan Cheung Tsang; Lai See Po; Ka Man Leung; Anita Lau; Wai Yi Siu; Randy Y C Poon
Journal:  FEBS Lett       Date:  2003-10-23       Impact factor: 4.124

Review 8.  The new tumor suppressor genes ING: genomic structure and status in cancer.

Authors:  Damien Ythier; Delphine Larrieu; Christian Brambilla; Elisabeth Brambilla; Rémy Pedeux
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

9.  Expression of the novel tumour suppressor p33(ING1)is independent of p53.

Authors:  K J Cheung; J A Bush; W Jia; G Li
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  Heterochromatin is refractory to gamma-H2AX modification in yeast and mammals.

Authors:  Jung-Ae Kim; Michael Kruhlak; Farokh Dotiwala; André Nussenzweig; James E Haber
Journal:  J Cell Biol       Date:  2007-07-16       Impact factor: 10.539

View more
  6 in total

Review 1.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

2.  A Functional Role for the Epigenetic Regulator ING1 in Activity-induced Gene Expression in Primary Cortical Neurons.

Authors:  Laura J Leighton; Qiongyi Zhao; Xiang Li; Chuanyang Dai; Paul R Marshall; Sha Liu; Yi Wang; Esmi L Zajaczkowski; Nitin Khandelwal; Arvind Kumar; Timothy W Bredy; Wei Wei
Journal:  Neuroscience       Date:  2017-11-20       Impact factor: 3.590

3.  ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanism.

Authors:  N Bigot; C Guérillon; S Loisel; N Bertheuil; L Sensebé; K Tarte; R Pedeux
Journal:  Cell Death Dis       Date:  2015-01-22       Impact factor: 8.469

Review 4.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 5.  Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation.

Authors:  Jérôme Archambeau; Alice Blondel; Rémy Pedeux
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

6.  CG7379 and ING1 suppress cancer cell invasion by maintaining cell-cell junction integrity.

Authors:  Alexandra D Rusu; Zoe E Cornhill; Brenda Canales Coutiño; Marcos Castellanos Uribe; Anbarasu Lourdusamy; Zsuzsa Markus; Sean T May; Ruman Rahman; Marios Georgiou
Journal:  Open Biol       Date:  2021-09-08       Impact factor: 6.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.